Viewing Study NCT03138733


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-03-01 @ 1:46 PM
Study NCT ID: NCT03138733
Status: COMPLETED
Last Update Posted: 2023-11-08
First Post: 2017-04-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Sponsor: Basilea Pharmaceutica
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Staphylococcus Aureus Bacteremia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ceftobiprole, daptomycin, Staphylococcus aureus View
None Bacteremia, bloodstream infection View